Boston Scientific management to meet with Oppenheimer
Meeting to be held on November 15 hosted by Oppenheimer. Published first on TheFly – the ultimate source for real-time, market-moving ...
Boston Scientific closes acquisition of Axonics
Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an ...
Boston Scientific closes $3.7B Axonics deal after lengthy review
Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...
WBJournal10 小时
Boston Scientific completes $3.7B purchase of California bowel dysfunction company
Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.
Boston Scientific Corporation: Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...
MassDevice12 小时
Boston Scientific finalizes $3.7B acquisition of Axonics
Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).
Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...
波士顿科学完成收购Axonics
马萨诸塞州马尔伯勒 - 波士顿科学公司(NYSE:BSX)今天宣布，已完成对专门从事泌尿和肠道功能障碍医疗设备的Axonics公司(NASDAQ:AXNX)的收购。该交易以每股71美元的价格成交，Axonics的股权价值约为37亿美元，企业价值为33亿美元。 预计此次收购对波士顿科学2024年和2025年的调整后每股收益影响将保持中性，之后预计会产生增值效应。在GAAP基础上，由于摊销费用和收购相 ...